Subcutaneous administration of tocilizumab is effective in myointimal hyperplasia remodelling in refractory Takayasu arteritis. Reumatismo, [S. l.], v. 69, n. 4, p. 184–188, 2017. DOI: 10.4081/reumatismo.2017.1013. Disponível em: https://www.reumatismo.org/reuma/article/view/1013. Acesso em: 15 jun. 2025.